Delivery Order SPE2DR25D3303-SPE2DR26F63D8
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,967.08 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for RINVOQ ER 45 mg tablets (28-count units). This is a firm fixed-price, non-set-aside contract with a completion date of December 12, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value transaction within AmerisourceBergen's extensive portfolio of pharmaceutical supply contracts supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $47,825.80 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on November 28, 2025, with an ultimate completion date of December 1, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be...
- The Defense Logistics Agency awarded a delivery order valued at $45,395.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a $41,291.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a completion date of December 9, 2025. The award, issued on December 8, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $10,186.03 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30 count) on October 27, 2025, with completion expected by October 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents pharmaceutical procurement to support federal medical supply needs. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $7,101.17 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical delivery under the company's broader federal contracting relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $57,586.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units), with an ultimate completion date of September 16, 2025. This non-set-aside contract represents a competitive award issued to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose) valued at $27,031.70 under a firm fixed-price contract type. The award was made on December 2, 2025, with an ultimate completion date of December 3, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $64,798.07 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on November 10, 2025, with completion expected by November 12, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement relationship. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $167,433.28 to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (28-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...